TA
DGX icon

Thor Advisors’s Quest Diagnostics DGX Stock Holding History

Thor Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$10K Buy
+128
New +$13.3K 0.53% 90

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thor Advisors's DGX Position: Q1 2020 in Review

Thor Advisors opened a new position in Quest Diagnostics (DGX) in Q1 2020: 128 shares worth $10K. The stake represents 0.53% of the portfolio and ranks #90 among its holdings.

714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

  • Thor Advisors held 128 shares of Quest Diagnostics worth $10K as of Q1 2020.
  • Quest Diagnostics was a new Thor Advisors position in Q1 2020.
  • Quest Diagnostics made up 0.53% of Thor Advisors's portfolio in Q1 2020, its #90 holding.
  • 714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Thor Advisors's 13F filing for Q1 2020, filed 18 May 2020.